MICHAEL WAGNER: Open Payments
NPI 1073655825 · DANVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,273 in 131 payments from 24 companies in 2025. Trend: 2023 $1,960 · 2024 $2,485 · 2025 $3,273
Food & beverage: $3,273
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 27 | $739 |
| Lilly USA, LLC | 14 | $285 |
| Dexcom, Inc. | 4 | $233 |
| Amgen Inc. | 6 | $222 |
| ABBVIE INC. | 8 | $189 |
| Novo Nordisk Inc | 9 | $163 |
| Exact Sciences Corporation | 8 | $160 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $159 |
| GlaxoSmithKline, LLC. | 7 | $138 |
| Axsome Therapeutics, Inc. | 5 | $136 |
Products named: BREZTRI, MOUNJARO, AIRSUPRA, REXULTI, VRAYLAR, Kerendia, DEXCOM G7 GSS (161), REPATHA.
Industry payments across IL — which companies pay providers there.
